List of Tables
Table 1. Global Pharyngitis Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Pharyngitis Drug Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Pharyngitis Drug Market Competitive Situation by Manufacturers in 2024
Table 4. Global Pharyngitis Drug Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Pharyngitis Drug Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Pharyngitis Drug Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Pharyngitis Drug Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Pharyngitis Drug Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Pharyngitis Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Pharyngitis Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Pharyngitis Drug, Product Type & Application
Table 12. Global Key Manufacturers of Pharyngitis Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pharyngitis Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharyngitis Drug as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Pharyngitis Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Pharyngitis Drug Sales by Region (2020-2025) & (K Units)
Table 18. Global Pharyngitis Drug Sales Market Share by Region (2020-2025)
Table 19. Global Pharyngitis Drug Sales by Region (2026-2031) & (K Units)
Table 20. Global Pharyngitis Drug Sales Market Share by Region (2026-2031)
Table 21. Global Pharyngitis Drug Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Pharyngitis Drug Revenue Market Share by Region (2020-2025)
Table 23. Global Pharyngitis Drug Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Pharyngitis Drug Revenue Market Share by Region (2026-2031)
Table 25. North America Pharyngitis Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Pharyngitis Drug Sales by Country (2020-2025) & (K Units)
Table 27. North America Pharyngitis Drug Sales by Country (2026-2031) & (K Units)
Table 28. North America Pharyngitis Drug Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Pharyngitis Drug Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Pharyngitis Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Pharyngitis Drug Sales by Country (2020-2025) & (K Units)
Table 32. Europe Pharyngitis Drug Sales by Country (2026-2031) & (K Units)
Table 33. Europe Pharyngitis Drug Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Pharyngitis Drug Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Pharyngitis Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Pharyngitis Drug Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Pharyngitis Drug Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Pharyngitis Drug Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Pharyngitis Drug Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Pharyngitis Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Pharyngitis Drug Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Pharyngitis Drug Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Pharyngitis Drug Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Pharyngitis Drug Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Pharyngitis Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Pharyngitis Drug Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Pharyngitis Drug Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Pharyngitis Drug Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Pharyngitis Drug Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Pharyngitis Drug Sales (K Units) by Type (2020-2025)
Table 51. Global Pharyngitis Drug Sales (K Units) by Type (2026-2031)
Table 52. Global Pharyngitis Drug Sales Market Share by Type (2020-2025)
Table 53. Global Pharyngitis Drug Sales Market Share by Type (2026-2031)
Table 54. Global Pharyngitis Drug Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Pharyngitis Drug Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Pharyngitis Drug Revenue Market Share by Type (2020-2025)
Table 57. Global Pharyngitis Drug Revenue Market Share by Type (2026-2031)
Table 58. Global Pharyngitis Drug Price (US$/Unit) by Type (2020-2025)
Table 59. Global Pharyngitis Drug Price (US$/Unit) by Type (2026-2031)
Table 60. Global Pharyngitis Drug Sales (K Units) by Application (2020-2025)
Table 61. Global Pharyngitis Drug Sales (K Units) by Application (2026-2031)
Table 62. Global Pharyngitis Drug Sales Market Share by Application (2020-2025)
Table 63. Global Pharyngitis Drug Sales Market Share by Application (2026-2031)
Table 64. Global Pharyngitis Drug Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Pharyngitis Drug Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Pharyngitis Drug Revenue Market Share by Application (2020-2025)
Table 67. Global Pharyngitis Drug Revenue Market Share by Application (2026-2031)
Table 68. Global Pharyngitis Drug Price (US$/Unit) by Application (2020-2025)
Table 69. Global Pharyngitis Drug Price (US$/Unit) by Application (2026-2031)
Table 70. Genentech Inc Company Information
Table 71. Genentech Inc Description and Business Overview
Table 72. Genentech Inc Pharyngitis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Genentech Inc Pharyngitis Drug Product
Table 74. Genentech Inc Recent Developments/Updates
Table 75. Adamas Pharmaceutical Inc Company Information
Table 76. Adamas Pharmaceutical Inc Description and Business Overview
Table 77. Adamas Pharmaceutical Inc Pharyngitis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Adamas Pharmaceutical Inc Pharyngitis Drug Product
Table 79. Adamas Pharmaceutical Inc Recent Developments/Updates
Table 80. PLIVA HRVATSKA d.o.o Company Information
Table 81. PLIVA HRVATSKA d.o.o Description and Business Overview
Table 82. PLIVA HRVATSKA d.o.o Pharyngitis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. PLIVA HRVATSKA d.o.o Pharyngitis Drug Product
Table 84. PLIVA HRVATSKA d.o.o Recent Developments/Updates
Table 85. Pfizer Inc Company Information
Table 86. Pfizer Inc Description and Business Overview
Table 87. Pfizer Inc Pharyngitis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Pfizer Inc Pharyngitis Drug Product
Table 89. Pfizer Inc Recent Developments/Updates
Table 90. Valeant Pharmaceuticals International, Inc Company Information
Table 91. Valeant Pharmaceuticals International, Inc Description and Business Overview
Table 92. Valeant Pharmaceuticals International, Inc Pharyngitis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Valeant Pharmaceuticals International, Inc Pharyngitis Drug Product
Table 94. Valeant Pharmaceuticals International, Inc Recent Developments/Updates
Table 95. Mylan N.V Company Information
Table 96. Mylan N.V Description and Business Overview
Table 97. Mylan N.V Pharyngitis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Mylan N.V Pharyngitis Drug Product
Table 99. Mylan N.V Recent Developments/Updates
Table 100. GSK group of companies Company Information
Table 101. GSK group of companies Description and Business Overview
Table 102. GSK group of companies Pharyngitis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. GSK group of companies Pharyngitis Drug Product
Table 104. GSK group of companies Recent Developments/Updates
Table 105. Teva Pharmaceutical Industries Ltd Company Information
Table 106. Teva Pharmaceutical Industries Ltd Description and Business Overview
Table 107. Teva Pharmaceutical Industries Ltd Pharyngitis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Teva Pharmaceutical Industries Ltd Pharyngitis Drug Product
Table 109. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 110. AbbVie Inc Company Information
Table 111. AbbVie Inc Description and Business Overview
Table 112. AbbVie Inc Pharyngitis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. AbbVie Inc Pharyngitis Drug Product
Table 114. AbbVie Inc Recent Developments/Updates
Table 115. Viatris Inc. (Mylan) Company Information
Table 116. Viatris Inc. (Mylan) Description and Business Overview
Table 117. Viatris Inc. (Mylan) Pharyngitis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Viatris Inc. (Mylan) Pharyngitis Drug Product
Table 119. Viatris Inc. (Mylan) Recent Developments/Updates
Table 120. GlaxoSmithKline plc Company Information
Table 121. GlaxoSmithKline plc Description and Business Overview
Table 122. GlaxoSmithKline plc Pharyngitis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. GlaxoSmithKline plc Pharyngitis Drug Product
Table 124. GlaxoSmithKline plc Recent Developments/Updates
Table 125. Abbott Laboratories Company Information
Table 126. Abbott Laboratories Description and Business Overview
Table 127. Abbott Laboratories Pharyngitis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Abbott Laboratories Pharyngitis Drug Product
Table 129. Abbott Laboratories Recent Developments/Updates
Table 130. Amgen Inc Company Information
Table 131. Amgen Inc Description and Business Overview
Table 132. Amgen Inc Pharyngitis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Amgen Inc Pharyngitis Drug Product
Table 134. Amgen Inc Recent Developments/Updates
Table 135. Sanofi-aventis Groupe Company Information
Table 136. Sanofi-aventis Groupe Description and Business Overview
Table 137. Sanofi-aventis Groupe Pharyngitis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Sanofi-aventis Groupe Pharyngitis Drug Product
Table 139. Sanofi-aventis Groupe Recent Developments/Updates
Table 140. Purdue Pharma L.P Company Information
Table 141. Purdue Pharma L.P Description and Business Overview
Table 142. Purdue Pharma L.P Pharyngitis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Purdue Pharma L.P Pharyngitis Drug Product
Table 144. Purdue Pharma L.P Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Pharyngitis Drug Distributors List
Table 148. Pharyngitis Drug Customers List
Table 149. Pharyngitis Drug Market Trends
Table 150. Pharyngitis Drug Market Drivers
Table 151. Pharyngitis Drug Market Challenges
Table 152. Pharyngitis Drug Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of Pharyngitis Drug
Figure 2. Global Pharyngitis Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Pharyngitis Drug Market Share by Type: 2024 & 2031
Figure 4. Tablet Product Picture
Figure 5. Capsule Product Picture
Figure 6. Spray Product Picture
Figure 7. Solution Product Picture
Figure 8. Other Product Picture
Figure 9. Global Pharyngitis Drug Market Value by Application (2020-2031) & (US$ Million)
Figure 10. Global Pharyngitis Drug Market Share by Application: 2024 & 2031
Figure 11. Hospital Pharmacies
Figure 12. Retail Pharmacies
Figure 13. Online Pharmacies
Figure 14. Global Pharyngitis Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Pharyngitis Drug Market Size (2020-2031) & (US$ Million)
Figure 16. Global Pharyngitis Drug Sales (2020-2031) & (K Units)
Figure 17. Global Pharyngitis Drug Average Price (US$/Unit) & (2020-2031)
Figure 18. Pharyngitis Drug Report Years Considered
Figure 19. Pharyngitis Drug Sales Share by Manufacturers in 2024
Figure 20. Global Pharyngitis Drug Revenue Share by Manufacturers in 2024
Figure 21. Global 5 and 10 Largest Pharyngitis Drug Players: Market Share by Revenue in Pharyngitis Drug in 2024
Figure 22. Pharyngitis Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Global Pharyngitis Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 24. North America Pharyngitis Drug Sales Market Share by Country (2020-2031)
Figure 25. North America Pharyngitis Drug Revenue Market Share by Country (2020-2031)
Figure 26. United States Pharyngitis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Canada Pharyngitis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Europe Pharyngitis Drug Sales Market Share by Country (2020-2031)
Figure 29. Europe Pharyngitis Drug Revenue Market Share by Country (2020-2031)
Figure 30. Germany Pharyngitis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. France Pharyngitis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. U.K. Pharyngitis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Italy Pharyngitis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Russia Pharyngitis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Asia Pacific Pharyngitis Drug Sales Market Share by Region (2020-2031)
Figure 36. Asia Pacific Pharyngitis Drug Revenue Market Share by Region (2020-2031)
Figure 37. China Pharyngitis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Japan Pharyngitis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. South Korea Pharyngitis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. India Pharyngitis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Australia Pharyngitis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. China Taiwan Pharyngitis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Indonesia Pharyngitis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Thailand Pharyngitis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Malaysia Pharyngitis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Latin America Pharyngitis Drug Sales Market Share by Country (2020-2031)
Figure 47. Latin America Pharyngitis Drug Revenue Market Share by Country (2020-2031)
Figure 48. Mexico Pharyngitis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Brazil Pharyngitis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Argentina Pharyngitis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Middle East and Africa Pharyngitis Drug Sales Market Share by Country (2020-2031)
Figure 52. Middle East and Africa Pharyngitis Drug Revenue Market Share by Country (2020-2031)
Figure 53. Turkey Pharyngitis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Saudi Arabia Pharyngitis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. UAE Pharyngitis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Global Sales Market Share of Pharyngitis Drug by Type (2020-2031)
Figure 57. Global Revenue Market Share of Pharyngitis Drug by Type (2020-2031)
Figure 58. Global Pharyngitis Drug Price (US$/Unit) by Type (2020-2031)
Figure 59. Global Sales Market Share of Pharyngitis Drug by Application (2020-2031)
Figure 60. Global Revenue Market Share of Pharyngitis Drug by Application (2020-2031)
Figure 61. Global Pharyngitis Drug Price (US$/Unit) by Application (2020-2031)
Figure 62. Pharyngitis Drug Value Chain
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
